EXTRA-RENAL LUPUS (ERL)

Clinical trials for EXTRA-RENAL LUPUS (ERL) explained in plain language.

Never miss a new study

Get alerted when new EXTRA-RENAL LUPUS (ERL) trials appear

Sign up with your email to follow new studies for EXTRA-RENAL LUPUS (ERL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New Double-Targeting drug enters first human test for severe lupus

Disease control Recruiting now

This is a first-in-human study to test the safety and find the right dose of a new drug, HB2198, for people with moderate to severe lupus. About 30 participants with active lupus, including kidney involvement, will receive two doses of the drug and be followed for a year. The mai…

Matched conditions: EXTRA-RENAL LUPUS (ERL)

Phase: PHASE1 • Sponsor: Hinge Bio • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

EXTRA-RENAL LUPUS (ERL)

Get alerted when new EXTRA-RENAL LUPUS (ERL) trials appear

New Double-Targeting drug enters first human test for severe lupus